Saethre-Chotzen syndrome (SCS), one of the most common forms of syndromic craniosynostosis (premature fusion of the cranial sutures), results from haploinsufficiency of TWIST1, caused by deletions of the entire gene or loss-of-function variants within the coding region. To determine whether non-coding variants also contribute to SCS, we screened 14 genetically undiagnosed SCS patients using targeted capture sequencing, and identified novel single nucleotide variants (SNVs) in the 5 ′ untranslated region (UTR) of TWIST1 in two unrelated SCS cases. We show experimentally that these variants, which create translation start sites in the TWIST1 leader sequence, reduce translation from the main open reading frame (mORF). This is the first demonstration that non-coding SNVs of TWIST1 can cause SCS, and highlights the importance of screening the 5 ′ UTR in clinically diagnosed SCS patients without a coding mutation. Similar 5 ′ UTR variants, particularly of haploinsufficient genes, may represent an under-ascertained cause of monogenic disease.
SCS patients using targeted capture sequencing, and identified novel single nucleotide variants (SNVs) in the 5 ′ untranslated region (UTR) of TWIST1 in two unrelated SCS cases. We show experimentally that these variants, which create translation start sites in the TWIST1 leader sequence, reduce translation from the main open reading frame (mORF). This is the first demonstration that non-coding SNVs of TWIST1 can cause SCS, and highlights the importance of screening the 5 ′ UTR in clinically diagnosed SCS patients without a coding mutation. Similar 5 ′ UTR variants, particularly of haploinsufficient genes, may represent an under-ascertained cause of monogenic disease.
K E Y W O R D S
haploinsufficiency, Saethre-Chotzen syndrome (SCS), TWIST1, upstream AUG (uAUG) , upstream open reading frame (uORF) Craniosynostosis, a malformation of skull development caused by premature fusion of one or more of the cranial sutures, affects around 1 in 2100 children (Lajeunie, Le Merrer, Bonaïti-Pellie, Marchac, & Renier, 1995) . A genetic cause accounts for ∼25% of craniosynostosis cases, most frequently due to coding mutations in FGFR2, FGFR3, and TWIST1 (Wilkie, Johnson, & Wall, 2017) . Heterozygous mutations of TWIST1 (MIM# 601622) result in Saethre-Chotzen syndrome (SCS; MIM# 101400) and typical features include coronal craniosynostosis, hypertelorism, ptosis, low frontal hairline, blocked tear ducts, and small dysmorphic ears (El Ghouzzi et al., 1997; Howard, et al., 1997) .
TWIST1 encodes a basic helix-loop-helix transcription factor that regulates a variety of processes, including calvarial development, where it has important roles in boundary formation at the coronal This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. suture (Merrill et al., 2006) and in inhibiting premature osteogenesis in sutural mesenchyme (Bialek et al., 2004; Yen, Ting, & Maxson, 2010) .
TWIST1 binds DNA as a homo-or heterodimer and the key basic helix-loop-helix partner in coronal suture formation and integrity is TCF12 (Sharma et al., 2013) . Heterozygous loss-of-function point mutations within the TWIST1 coding region and monoallellic wholegene deletions have been reported in patients with SCS, consistent with haploinsufficiency of TWIST1 as the underlying causative mechanism (El Ghouzzi et al., 1997; Howard, et al., 1997; Johnson et al., 1998) . As reduced expression of TWIST1 could also be caused by mutation of non-coding regulatory elements, we set out to screen the entire gene in SCS cases who were negative for known causes of craniosynostosis.
As part of a wider study, we designed a resequencing capture panel to the TWIST1 gene and flanking regions (2.4 Mb design with boundaries selected using human to mouse synteny; chr7: 17346143-19695462, GRCh38) and used this in the analysis of 14 SCS cases in whom no mutation of TWIST1 or other craniosynostosis-associated genes had been identified (genetic screening was documented in all cases for TWIST1, and in the majority of cases for TCF12, FGFR2
exons IIIa and IIIc, and FGFR3 exon7 (Wilkie et al., 2017) (Bolger, Lohse, & Usadel, 2014) .
Trimmed read pairs were aligned to human reference genome hg19 using BWA (v0.7.12) in paired-end mode with default parameters (Li & Durbin, 2009 ). Target coverage was calculated using BEDtools v0.25.0 (Quinlan & Hall, 2010) and processed using amplimap (v0.2.9, https://github.com/koelling/amplimap). An average depth of >100× was achieved (Supp. Table S1 ). Variants were called separately in each sample using Platypus (v0.8.1) (Rimmer et al., 2014) . Variant calls were then concatenated, merged, and normalized using BCFtools (v1.5, https://github.com/samtools/bcftools) and annotated using Annovar (Wang, Li, & Hakonarson, 2010) .
Here, we report on our analysis of the TWIST1 genomic sequence.
We searched (June 2017) for variants that were not listed in public databases of variation, including the 1000 Genomes Project (https:// www.internationalgenome.org) and gnomAD (https://gnomad. broadinstitute.org), and this identified three variants within the entire TWIST1 sequence, all within the 5 ′ UTR, in 2 of the 14 SCS probands (Supp. Figure S1A Figure S1B ). Dideoxy-sequencing showed that this variant was inherited from the apparently unaffected father (I-1; Figure 1E ).
Mosaicism of the variant in I-1 was excluded in DNA from both peripheral blood and saliva by deep sequencing (data not shown). II-2 had bicoronal synostosis with brachycephaly, mild hypertelorism, and facial appearance consistent with SCS ( Figure 1F Figure 2A) ; importantly, no such sequences are present in the wild-type (WT) TWIST1 5 ′ UTR, either in humans or in all other vertebrate species that we were able to analyse (Supp. Figure S2 ). The sequence contexts at these positions both provide good matches with the Kozak consensus (Kozak, 1986) for translation initiation, and analysis using the prediction tools DNA functional site miner (DNAFSMiner; https://dnafsminer.bic.nus.edu.sg/), NetStart (https://www.cbs.dtu.dk/services/NetStart/), and ATGpr (https://atgpr.dbcls.jp/) suggested that both uAUGs could potentially compete with the endogenous TWIST1 start AUG (sAUG) as translation initiation sequences ( Figure 2B) . A purine at -3 from the AUG is the most functionally important residue (Kozak, 1986) To test whether any of the three 5 ′ UTR variants might be associated with down-regulation of TWIST1 protein output, we carried out functional assays using a dual luciferase reporter transfected into HEK293T cells, as previously described (Calvo, Pagliarini, & Mootha, 2009; Twigg et al., 2013) . The WT sequence of the full-length TWIST1 5 ′ UTR was amplified and cloned into the psiCHECK-2 dual-luciferase reporter (Calvo et al., 2009) , so that Renilla luciferase translation initiated at the sAUG of TWIST1. This construct was further modified by site-directed mutagenesis (New England Biolabs) to introduce specific variants into the 5 ′ UTR sequence, including the individual variants carried by the two SCS probands (Supp. Table S2 ). All constructs were verified by dideoxy-sequencing, and fluorimetric assays were Figure 2D , i-ii). As the -255 uAUG is in-frame and has a slightly weaker Kozak consensus that the sAUG, our expectation was that two Renilla proteins differing by an 85 amino acid N-terminal extension (∼9 kDa) would be produced. To investigate the relative reduction in Renilla luciferase activity further, we analyzed both the RNA and protein produced in the assay. We found no difference in the amount of RNA produced by the c.-255 and WT constructs in a reverse transcription quantitative PCR (RT-qPCR) analysis (normalized against firefly expression; for primers and methods, see Supp Table S2 ) of transfected HEK293 cells ( Figure 2E ). We then looked for expression of the larger protein by western blot analysis of reporter assay lysates using an antibody against Renilla (Abcam ab185925). This showed that the presence of the c.-255 uAUG led to a dramatic reduction in Renilla expression, and that there was no evidence of a larger fusion protein ( Figure 2E ). Renilla expression was completely restored when a stop codon was introduced at c.-246, suggesting that in the context of a small uORF (three codons), the uAUG does not substantially impact on translation from the sAUG.
Finally, we confirmed that the -255 uAUG functions as a translation (Kozak, 1986) aligned to the uAUGs of Families 1 and 2, and to the TWIST1 start codon (sAUG). The relative strengths of these possible translation initiation sequences were assessed by three online tools, DNA functional site miner (DNAFSMiner), NetStart, and ATGpr with scores shown on the right. C: Luciferase analysis to determine the effect of the Family 1, 5 ′ UTR variants on translation. Luciferase reporter DNA constructs are shown on the left and normalized luciferase activity generated from each is shown on the right. 3 and 4) , from separate experiments. The N-terminal extension produced by translation from c.-255 uAUG is predicted to increase the molecular weight of Renilla by ∼9 kDa, but a larger product was not detected. Anti-Renilla luciferase antibody (Abcam ab185925) and -tubulin (Santa Cruz, sc-32293) at 1/1000 dilutions were used against 10 g of protein lysate (BCA protein assay kit, Thermo) start site by using a construct with a uORF of similar size to that identified in Family 1 (Figure 2D, iv) . This analysis showed a similar knock-down effect on Renilla expression (73.16% ± 8.64%), supporting the fact that the c.-255 uAUG is recognized and engaged by the translational machinery. Taken together, the luciferase data suggest that the c.-255G > A variant could lead to suppressed translation from the sAUG, or preferential production of the N-terminally extended protein which is highly unstable.
Regulatory elements within the 5 ′ UTR of mature mRNAs are important contributors to the post-transcriptional control of gene expression and include uAUGs, uORFs, and internal ribosome entry sites (Mignone & Pesole, 2016) . Translation of the majority of eukaryotic mRNAs is by the scanning mechanism, whereby the 43S preinitiation complex first binds to the 5 ′ cap, then scans along the leader sequence for the first AUG codon present in a suitable context. Secondary structure and elements such as uAUGs and uORFs can affect ribosome scanning efficiency and thus modulate the level of translation of the main coded protein, and both uAUGs and uORFs are found at a lower than expected frequency in 5 ′ UTRs (Iacono, Mignone, & Pesole, 2005) . Approximately 50% of mammalian 5 ′ UTRs contain uORFs that generally act as repressive regulators of gene activity (Calvo et al., 2009; Johnstone, Bazzini, & Giraldez, 2016; Ye et al., 2015) , with control of translation mediated through several different mechanisms (Cabrera-Quio, Herberg, & Pauli, 2016; Wethmar, 2014) . The number of diseases known to be caused by mutations that introduce or disrupt uORFs is increasing (Barbosa, Onofre, & Romao, 2014; Calvo et al., 2009; Chatterjee, Rao, & Pal, 2017) Figure S3A) , and TWIST1 is unusual in having a relatively long 5 ′ UTR without an uAUG (Supp. Figure S3B Interpretation of the c.-255G > A variant in Family 2 is more challenging, as the variant introduces an uAUG that is in-frame with the main TWIST1 coding sequence, and there was apparent incomplete penetrance of the SCS phenotype in the father I-1. That in-frame uAUGs can affect translation from the mORF is supported by the observation that such codons are suppressed in the 5 ′ UTRs of mammalian genes, strikingly even more so than uORFs or out-of-frame uAUGs (Iacono et al., 2005) . Translation start site choice is influenced by distance from the cap, sequence context, secondary structure, and the availability of eukaryotic initiation factors (reviewed in Brar, 2016; Hinnebusch, Ivanov, & Sonenberg, 2016) . If an uAUG is recognized by the preinitiation complex then this might act as a soak for ribosomes and moreover, translation of the mORF cannot occur through reinitiation but only through either leaky scanning, which will be influenced by the strength of the Kozak consensus, or perhaps through ribosome shunting, where parts of the 5 ′ UTR are physically bypassed.
Our results show that although the c.-255 uAUG sequence context is marginally weaker than that of the sAUG, it is recognized by the ribosomal machinery as translation of the mORF is reduced when the uAUG is in-frame with the main coding sequence or a distant upstream termination codon. Translation resulting in N-terminal extension because of an in-frame uAUG (or "near-cognate" translation start sites with a single base substitution of AUG) has been demonstrated by ribosomal profiling (Fields et al., 2015; Fritsch et al., 2012; Ingolia, Lareau, & Weissman, 2011) . In a normal physiological setting this process may regulate translation of the primary ORF (Karagyozov et al., 2008; Song et al., 2010) as well as production of different isoforms (Calkhoven, Muller, & Leutz, 2000) and their subcellular localization (Touriol et al., 2003) . However, a non-physiological N-terminal addition to a protein can have detrimental effects on structure, stability, or targeting. In relation to the TWIST1 uAUG found in Family 2, factors such as AUG choice, stability, and function of an extended protein if produced, as well as expression levels from the WT allele, will in combination determine whether there is sufficient functional TWIST1 protein for development. This balance may be close to the TWIST1 dosage threshold for normal development, providing a possible explanation for phenotypic variation found in the two mutation-positive individuals in Family 2.
In summary, we have identified the first non-coding point mutations in SCS, and demonstrate that they cause a reduction in TWIST1 expression at the level of translation. It is likely that similar variants are present in other dosage-sensitive genes and represent an underascertained pool of causal mutations within 5 ′ UTRs. Such regions are often excluded in diagnostic screening, or poorly covered because of GC-richness, but with the increased use of, and improvement in, whole genome sequencing, more potentially pathological non-coding variants will be identified and require clinical interpretation. In craniosynostosis, pathological variants have been identified in the 5 ′ UTRs of EFNB1 (Romanelli Tavares et al., 2018; Twigg et al., 2013) and SMAD6 (E.C., unpublished data), highlighting the importance of screening these sequences in patients with a clear diagnosis and where a coding mutation or deletion cannot be identified.
